APA (7th ed.) Citation

Rischke, N., Kanbach, J., & Haug, U. Utilization of EGFR, ALK, and BRAF Inhibitors in the Treatment of Lung Cancer in Germany. Wiley.

Chicago Style (17th ed.) Citation

Rischke, Nikolaj, Josephine Kanbach, and Ulrike Haug. Utilization of EGFR, ALK, and BRAF Inhibitors in the Treatment of Lung Cancer in Germany. Wiley.

MLA (9th ed.) Citation

Rischke, Nikolaj, et al. Utilization of EGFR, ALK, and BRAF Inhibitors in the Treatment of Lung Cancer in Germany. Wiley.